Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Total Debt: 2013-2025

Historic Total Debt for Amphastar Pharmaceuticals (AMPH) over the last 12 years, with Sep 2025 value amounting to $609.5 million.

  • Amphastar Pharmaceuticals' Total Debt rose 2.15% to $609.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $609.5 million, marking a year-over-year increase of 2.15%. This contributed to the annual value of $601.9 million for FY2024, which is 2.01% up from last year.
  • As of Q3 2025, Amphastar Pharmaceuticals' Total Debt stood at $609.5 million, which was up 0.14% from $608.7 million recorded in Q2 2025.
  • Over the past 5 years, Amphastar Pharmaceuticals' Total Debt peaked at $638.6 million during Q3 2023, and registered a low of $38.5 million during Q2 2021.
  • Its 3-year average for Total Debt is $546.1 million, with a median of $596.7 million in 2024.
  • Its Total Debt has fluctuated over the past 5 years, first decreased by 17.47% in 2021, then surged by 743.74% in 2023.
  • Amphastar Pharmaceuticals' Total Debt (Quarterly) stood at $77.0 million in 2021, then declined by 1.42% to $75.9 million in 2022, then soared by 677.51% to $590.0 million in 2023, then climbed by 2.01% to $601.9 million in 2024, then increased by 2.15% to $609.5 million in 2025.
  • Its Total Debt was $609.5 million in Q3 2025, compared to $608.7 million in Q2 2025 and $604.1 million in Q1 2025.